Arteriovenous Fistula (AVF): Causes, Symptoms, Diagnosis and Treatment — Overview, Diagnosis & Treatment Options | MyMedicPlus

An arteriovenous fistula (AVF) is an abnormal direct connection between an artery and a vein that bypasses the capillary bed, resulting in high-flow, pulsatile arterial blood being delivered directly into the low-pressure venous circulation. AVFs may be congenital (arising from developmental vascular anomalies — arteriovenous malformations, or AVMs), acquired (post-traumatic, iatrogenic, or arising from vascular pathology), or deliberately created surgically as vascular access for hemodialysis in patients with end-stage renal disease (ESRD). Surgically created radiocephalic or brachiocephalic AVFs represent the gold-standard vascular access for hemodialysis, as recommended by the Kidney Disease Outcomes Quality Initiative (KDOQI) 2019 guidelines — AVFs offer the lowest infection rates, longest functional lifespan (average 5-10 years), lowest thrombosis risk, and best overall patient outcomes compared to arteriovenous grafts (AVGs) or central venous catheters (CVCs). Approximately 500,000 Americans require hemodialysis; vascular access dysfunction — primarily AVF stenosis and thrombosis — accounts for over 25% of all hospitalizations in dialysis patients and is a major cause of morbidity. In congenital cerebral AVMs, the Spetzler-Martin grading system (1-5) guides management decisions based on AVM size, eloquent brain location, and deep venous drainage pattern, predicting surgical risk and informing selection between microsurgery, stereotactic radiosurgery, and endovascular embolization.

AVF etiology varies fundamentally by subtype. Congenital arteriovenous malformations (AVMs): arise from aberrant vascular morphogenesis during embryogenesis — failure of normal differentiation between arterial and venous channels during weeks 4-8 of gestation; congenital brain AVMs occur in approximately 0.1% of the population; sporadic in the majority; hereditary hemorrhagic telangiectasia (HHT, autosomal dominant disorder caused by ENG or ACVRL1 gene mutations encoding endoglin or activin receptor-like kinase 1) causes multiple pulmonary, cerebral, hepatic, and spinal AVMs; brain AVMs may also occur in association with capillary malformation-AVM syndrome (RASA1/EPHB4 mutations) and Wyburn-Mason syndrome. Acquired traumatic AVF: penetrating trauma (knife and gunshot wounds to neck, extremities, abdomen) causing simultaneous arterial and venous laceration in proximity; iatrogenic causes — central venous catheter placement (particularly internal jugular and femoral approaches), arterial catheterization (cardiac catheterization and coronary intervention commonly create femoral AVF at the puncture site), renal or liver biopsy, and bone marrow biopsy; spontaneous AVF from aortic aneurysm eroding into an adjacent vein (aortocaval, aortoiliac-venous fistula). Dialysis AVF: deliberately created by surgical anastomosis of adjacent artery and vein — most commonly radiocephalic (Brescia-Cimino: radial artery to cephalic vein at the wrist, first described 1966), brachiocephalic (brachial artery to cephalic vein at the antecubital fossa), or brachiobasilic (requiring basilic vein transposition or elevation); AVF non-maturation risk factors: diabetes mellitus (arterial calcification and reduced vessel compliance), peripheral arterial disease, advanced age, female sex (smaller vessel caliber), prior ipsilateral CVC placement causing central venous stenosis, obesity, and low-quality forearm vessels on preoperative vascular mapping.

Clinical manifestations depend on AVF type, size, flow, and anatomical location. Dialysis AVF — normal findings indicating patency: palpable thrill (continuous vibration felt on light palpation over the fistula) and audible bruit (continuous machine-like murmur on auscultation with a stethoscope); arm vein distension and dilation. Dialysis AVF — complications: stenosis manifesting as reduced, bounding, or pulsatile change in thrill character; prolonged bleeding post-needling (above 20 minutes); inadequate blood flow rates during dialysis (below 300 mL/min); aneurysmal dilatation — a tortuous, saccular, or pulsatile deformity of the venous segment that may thrombose or rupture; thrombosis with complete absence of thrill and bruit accompanied by acute swelling and warmth; ischemic steal syndrome — hand coldness, pallor, or cyanosis distal to the AVF anastomosis, pain (particularly during dialysis), paresthesia, and fingertip ulceration or gangrene from arterial flow diverted away from the hand into the fistula. Congenital/acquired AVF — systemic effects: continuous audible bruit over the fistula site; palpable thrill and local skin warmth; limb hypertrophy and edema from venous hypertension; high-output cardiac failure (symptoms of dyspnea, exercise intolerance, tachycardia, and biventricular failure) — may occur with large-flow congenital AVMs or high-flow acquired AVFs when fistula flow exceeds 20-30% of cardiac output; varicose veins and chronic venous insufficiency distal to the fistula. Brain AVMs: headache, seizures, focal neurological deficits from adjacent tissue ischemia, or acute intracerebral hemorrhage (annual hemorrhage risk approximately 2-4% per year for unruptured brain AVMs).

Duplex ultrasound is the primary non-invasive investigation for all AVFs — it provides real-time B-mode visualization of vessel anatomy, color Doppler mapping of blood flow direction and turbulence, and spectral Doppler quantification of blood flow velocity (peak systolic velocity, end-diastolic velocity, and volume flow rate in mL/min). In dialysis AVFs, mature fistula parameters are: minimum vein diameter 4-5 mm, depth within 6 mm of skin surface, and blood flow above 500-600 mL/min — the 'Rule of 6s.' Pre-operative vascular mapping by duplex ultrasound is mandatory before AVF creation to identify adequate arteries (radial artery diameter above 2 mm at wrist) and veins (cephalic vein above 2-2.5 mm) — reduces non-maturation rates. CT angiography (CTA) or MR angiography (MRA): used for complex or central congenital AVMs, thoracic or abdominal acquired AVFs, and suspected central venous stenosis. Catheter-based fistulogram (contrast angiography): the gold standard imaging for diagnostic assessment and to guide endovascular intervention — provides high-resolution roadmap of the fistula circuit, anastomosis, outflow veins, and central venous anatomy; performed in the interventional radiology suite immediately before percutaneous transluminal angioplasty (PTA). Echocardiography: assesses cardiac function and output in patients with high-output cardiac failure from large-flow AVMs or AVFs. Brain AVMs: CT angiography (CTA) or MRI with gadolinium first-line; digital subtraction angiography (DSA) gold standard for anatomical characterization before intervention.

Dialysis AVF stenosis: percutaneous transluminal angioplasty (PTA) with a non-compliant balloon catheter (e.g., 5-7 mm diameter for venous stenosis, 4-6 mm for juxta-anastomotic stenosis) at the site of stenosis identified on fistulogram; clinical success (restoration of thrill and flow above 500 mL/min) is achieved in approximately 70-85% of cases; plain balloon PTA is first-line — drug-coated balloons (DCBs: paclitaxel-coated, e.g., IN.PACT AV, Lutonix AV) reduce restenosis rates compared to plain PTA (PATENCY trial: target lesion primary patency 82% vs 55% at 6 months with DCB); stent deployment reserved for elastic recoil or dissection post-PTA. AVF thrombosis: surgical thrombectomy (Fogarty catheter-directed thrombus extraction) or catheter-directed thrombolysis (alteplase 2-10 mg) followed by angioplasty of the underlying causative stenosis. AVF non-maturation: fistula salvage by angioplasty of stenotic segments, surgical ligation of accessory veins diverting flow (reducing fistula blood flow maturation), or transposition of the vein to a more superficial position. Dialysis steal syndrome: distal revascularization interval ligation (DRIL) procedure — creating a bypass from proximal artery to distal artery (below the fistula) to restore distal limb perfusion while ligating the native artery between fistula and bypass; fistula banding (reducing fistula diameter and flow) for mild steal; proximalization of arterial inflow (PAI) technique. Congenital/acquired non-cerebral AVF: transcatheter embolization using platinum coils, Onyx liquid embolic, or microspheres for peripheral AVMs — often requires multiple staged sessions for complex AVMs; open surgical ligation or resection for AVMs amenable to complete excision. Brain AVMs: Spetzler-Martin grade I-II — open microsurgical resection with curative intent; grade III — multidisciplinary decision between surgery, stereotactic radiosurgery (Gamma Knife, CyberKnife), or embolization; grades IV-V — typically managed conservatively or with palliative embolization; all AVMs with prior hemorrhage: active treatment recommended.

The prognosis for arteriovenous fistulas depends primarily on the type and anatomical location. Surgically created dialysis AVFs have excellent long-term patency when they mature and function adequately — primary unassisted patency rates are approximately 60-65% at 3 years for radiocephalic AVFs, improving to approximately 70-85% with endovascular intervention for stenosis. With regular surveillance and timely intervention, functional AVF lifespans of 5-10 years or more are achievable, making native AVF far superior to central venous catheters for dialysis patients. Non-maturation of newly created AVFs occurs in approximately 30-40% of cases; approximately 60-70% of these can be salvaged by angioplasty, accessory vein ligation, or surgical revision. Dialysis steal syndrome, if treated promptly with DRIL or banding, resolves hand ischemia in the vast majority of cases and preserves limb function. For well-functioning dialysis AVF patients, infection rates are dramatically lower than central venous catheters, and cardiovascular outcomes are significantly better. Congenital brain AVMs carry an annual hemorrhage risk of approximately 2-4% for unruptured lesions; completely obliterated AVMs confirmed by post-treatment angiography have hemorrhage risk approaching zero. Microsurgically resected Spetzler-Martin Grade I-II brain AVMs achieve obliteration in approximately 90-95% with low neurological complication rates. Radiosurgery achieves obliteration in approximately 70-80% of small-to-medium AVMs at 3 years, with excellent long-term quality of life after the 2-3 year latency period. Traumatic and iatrogenic peripheral AVFs treated with endovascular embolization or surgical ligation achieve closure in the large majority of cases, with resolution of symptoms including cardiac high-output failure and limb edema. Long-term complications to monitor include progressive AVF enlargement, aneurysm formation at the anastomosis site, and high-output cardiac failure from very high-flow fistulas requiring elective reduction.

For dialysis patients, maximising AVF maturation success requires early nephrology referral (at least 6 months before anticipated dialysis start) to allow time for pre-operative vascular mapping by duplex ultrasound, surgical creation, and adequate maturation time. Patients with chronic kidney disease should avoid venipuncture and peripheral IV lines in the forearm and antecubital veins of the non-dominant arm, preserving these vessels for future AVF creation. Optimal blood glucose and lipid control in diabetic patients and adequate management of peripheral arterial disease improve vessel quality and AVF outcomes. For congenital AVMs, avoiding repeated incomplete partial embolization — which may stimulate angiogenesis and worsen the lesion — and referring to centres with high-volume AVM experience reduces procedural risk.

Dialysis patients should report changes in the character of their fistula thrill (reduced, absent, or changed quality) immediately to their dialysis care team — these changes indicate developing stenosis or thrombosis that may be reversible if treated promptly. Hand pain, coldness, weakness, or sores on the fingertips after AVF creation may indicate steal syndrome and requires same-day vascular surgery evaluation. A pulsatile or continuous murmur mass developing after trauma, catheterisation, or surgery should be evaluated with duplex ultrasound for a traumatic AVF — high-output cardiac failure can develop if untreated. For CKD patients approaching dialysis, early referral to a vascular access clinic — at estimated GFR <20-25 mL/min — ensures adequate time for AVF planning, creation, and maturation before dialysis dependency.